MED12 and acute lymphoblastic leukemia: We found significantly higher mutation frequency in IF compared with responsive patients in two known T-ALL genes, WT1 (22.9% v 11.4%; P = .037) and MED12 (16.7% v 2.7%; P < .001; Fig 4B).